Biocatalytic platform for converting fatty acid methyl esters to linear 1-olefins
Innovative biocatalytic platform combining P450 enzyme OleT and lipases to convert fatty acid methyl esters into linear 1-olefins. This method enables sustainable production of valuable olefins using a novel enzymatic process.
Overview
This solution offers a novel biocatalytic method for converting fatty acid methyl esters into linear 1-olefins, utilizing the synergistic action of the P450 enzyme OleT and specific lipases. This approach aims to provide a sustainable and efficient pathway for olefin production, which is crucial for the chemical industry due to the versatility and utility of olefins.
Technical specifications
The core of this biocatalytic platform involves two enzymes: the P450 enzyme OleT, which catalyzes the oxidative decarboxylation of fatty acids to produce terminal olefins, and lipases, which can hydrolyze fatty acid methyl esters into methanol and fatty acids. By integrating these enzymes, the platform facilitates the conversion of fatty acid methyl esters into valuable linear 1-olefins. Key features include:
- P450 enzyme OleT: Known for its ability to catalyze terminal olefin production from fatty acids.
- Lipases: Efficiently hydrolyze fatty acid methyl esters, supporting the overall transformation process.
- Directed evolution: Further enhancement of enzyme activity to improve efficiency and adaptability under various conditions.
Technology readiness level
The current technology readiness level of this solution is 3, indicating that the core concept has been demonstrated in a laboratory environment. Future steps include screening and evolving enzyme sequences to maximize catalytic efficiency and adaptability under more challenging conditions.
About University of California, Santa Barbara
UC Santa Barbara is a comprehensive public research university with a collaborative, innovation‑driven culture. Industry partners engage through co‑located cleanrooms and prototyping suites, campus‑wide shared instrumentation, and flexible sponsored‑research agreements coordinated by an industry partnerships team. The coastal campus sits within a Central Coast technology corridor, supporting close collaboration, recruiting pipelines, capstone engagements, and short‑course training tailored to corporate needs. Research is sustained by competitive federal funding from NSF, DOE, DOD, and NIH. A dedicated technology transfer office manages IP, licensing, and startup formation to speed commercialization.
delivered to your inbox.